Drawing for DRITUBE III DRIEX TECHNOLOGY

USPTO serial 79371288

DRITUBE III DRIEX TECHNOLOGY

Reviewed by CopyMark Law Group

Reg. 7404274Status 700Registered
Filing date
Status date
Registration date
Jun 4, 2024
Examiner
WATSON, JULIE A
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with DRITUBE III DRIEX TECHNOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Zachary A.Aria

Zachary A.Aria Blank Rome LLPOne Logan Square8th FloorPhiladelphia, PA 19103

Goods and services

ClassDescriptionStatusFirst use
010Flasks for administering parenteral nutrition sold empty; dropper bottles for administering medication sold empty; vaporizers for medical purposes; suction bottles for medical use sold empty; syringes for medical purposes; syringes for injections; haemoperfusion cartridges sold empty; feeding bottles; droppers for administering medication, sold empty; medical trays for holding surgical instruments; spoons for administering medicine in doses; spoons for administering medicine; non-spill spoons for administering medication to infants; intravenous feeding bottles; breast milk storage bottles; medical tubing for administering drugs; injection device for pharmaceuticals; dropping pipettes for medical purposes; medical diagnostic devices for sale in kits, namely, diagnostic kits consisting primarily of probes, buffers, and reagents for use in microbial testing; consumable laboratory cartridges for medical diagnostic purposes; valves and valve accessories for intravenous drug administration sold empty; apparatus for kits for medical diagnostic purposes containing test pieces, analysis plates and indicator papers to assess the results of analyses being medical test kits for diabetes monitoring for home use; medical diagnostic test kits for clinical medical use for use in microbial testing, consisting primarily of test tubes, test plates and indicator charts for evaluating test results; containers especially designed for medical reagents waste; systems comprising medical apparatus and accessories for administering measured doses of medical substances and consisting primarily of fluid warmers, spoons for administering medicine, intravenous feeding tubes; medical instruments for recording physiological data for medical and pharmaceutical purposes; medical prostheses and implants for surgical purposes both made of artificial material; sterile containers specifically designed for carrying medical products; sterile containers for surgical purposes; empty medical diagnostic cartridges of plastic for containing and administering medical products; empty medical diagnostic cartridges of glass for containing and administering medical products; empty medical diagnostic cartridges of plastic for containing and administering reagents; empty medical diagnostic cartridges of glass for containing and administering reagents; medical needles of metal for parenteral administration; auxiliary medical devices for drug reconstitution; cartridges of plastic for medical diagnostic purposes, namely, medical apparatus in the nature of infusion and injection devices for administering drugs; containers made of glass or plastic for pharmaceutical or parapharmaceutical or medical use, namely, empty dropper bottles for injectable substances, syringes and empty medical diagnostic cartridgesACTIVE—
020Container closures of plastic; plastic medication containers for commercial use; containers, not of metal for transporting and holding pharmaceuticals; bottle closures, not of metal; closures for containers, non-metallic; plastic medication containers for commercial use; corks for bottles; plastic stoppers for bottles; screw caps and caps of plastic for the closure of containers; sealing caps, not of metal; closures of plastics for containers with tampering detection built inACTIVE—
021Cruets; cruet stands; containers for household use, namely, glass bulbs; flasks; flasks of plastic; empty spray bottles; glass cartridges for medication for personal use and sold empty; pill boxes for personal use; personal dispensers for pills or capsules for domestic use; droppers for cosmetic purposes; glass boxes; bottles sold empty; glass flasks; plastic beverage bottles sold empty; drip preventers for bottles in the nature of bottle pourers; glass stoppers for bottles; bottles for pharmaceuticals sold empty; apothecary jars sold empty; dispensers for liquids for use with bottles in the nature of bottle pourers; containers made of glass or plastic for pharmaceutical or parapharmaceutical or medical use, namely, bottles for medicines, bottles for reagents, bottles for infusions, bottles for aerosols, vials, ampoules, pill bottles all sold empty; medicinal bottle stoppers of glass for domestic useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 7, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 19, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 19, 2024FIMPFINAL DISPOSITION PROCESSED—
Sep 4, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 4, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 4, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 19, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 19, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 28, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 30, 2024PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jan 30, 2024PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jan 16, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 12, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 12, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jan 12, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 12, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 12, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 12, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 12, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 12, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 12, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 7, 2023RFNTREFUSAL PROCESSED BY IB—
Jul 14, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 14, 2023RFRRREFUSAL PROCESSED BY MPU—
Jun 13, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 10, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 9, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 9, 2023DOCKASSIGNED TO EXAMINER—
Jun 9, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 8, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance